Pazopanib

Image of Pazopanib medication, used in targeted therapy for advanced kidney cancer and soft tissue sarcoma.

Anticancer Drug (Alkyldiarylamines Derivative)

Kidney cancer Soft tissue sarcoma

Why Partner with Pinnacle Life Science

Regulatory Compliance

Manufactured under WHO-GMP compliant processes at our US FDA approved facility in Baddi, Himachal Pradesh.

Consistent Quality

Rigorous quality control at every stage ensures reliable purity and potency across every batch produced.

Global Reach

Trusted by pharmaceutical partners and distributors across 90+ countries worldwide.

Mechanism of Action

Tyrosine kinase (multikinase) inhibitor; limits tumor growth via inhibition of angiogenesis by inhibiting cell surface vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3), platelet-derived growth factor receptors (PDGFR-alpha and -beta), fibroblast growth factor receptor (FGFR-1 and -3), cytokine receptor (cKIT), interleukin-2 receptor inducible T-cell kinase, lymphocyte-specific protein tyrosine kinase (Lck), and transmembrane glycoprotein receptor tyrosine kinase (c-Fms)

Contact Us

    Download The Brochure